Vacancy: Editor-in-Chief for ATLA

Frame > News > Vacancy: Editor-in-Chief for ATLA

Vacancy: Editor-in-Chief for ATLA

 Alternatives to Laboratory Animals (ATLA) is a peer reviewed journal, published by SAGE in partnership with FRAME (Fund for the Replacement of Animals in Medical Experiments). FRAME is a charity that was founded in 1969,and is currently based in Nottingham, UK. 

FRAME is currently looking for an Editor-in Chief to join their highly experienced existing ATLA team of Managing Editor, Technical Editor and Associate Editor.

ATLA has a multi-national Editorial Board. It covers all aspects of the development, validation, implementation and use of alternatives to laboratory animals in biomedical research and toxicity testing. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo experiments that are still carried out.

The journal publishes original research papers, review articles, letters, comments and book reviews. It is of relevance to research scientists, academics, and those involved in regulatory affairs or in the field of animal ethics. The papers published commonly feature in vitroex vivo or in silico methods; surveys on the use of animals for education, research or testing purposes; humane teaching or medical training methods; and the optimisation and validation of novel or existing methods for use as non-animal alternatives.

Responsibilities of the Editor-in-Chief role include: 

  • Making final decisions on the publication of all articles submitted to the journal, based on the reviewers’ comments, recommendations from the Associate Editors and your own opinion of the papers
  • Ensuring that the peer review of the journal submissions is carried out to the highest ethical standards (via the ScholarOne Manuscripts online submission system) in accordance with SAGE policies and processes
  • Using your own network of contacts to positively evolve the Editorial Board
  • Working with the existing ATLA team, as well as the FRAME Trustees and SAGE Publishing, to strategically develop the Journal, with a particular focus on ensuring only high quality content is accepted for publication with an aim to further increasing the journal’s Impact Factor
  • Taking a proactive role in soliciting submissions and encouraging interest in the journal
  • Representing ATLA as Editor-in-Chief at external events and promoting the journal whenever possible, with the ongoing support of FRAME and SAGE
  • Striving to ensure that enough copy is accepted for the journal to publish to schedule
  • Signing off the content for each issue, after its proofreading by the Managing Editor and the Technical Editor
  • Arranging at least one Editorial Board meeting per year, possibly as part of an existing international conference, or as a teleconference
  • Attending FRAME Trustees meetings upon request, to provide feedback on journal performance
  • Taking part in progress meetings and teleconferences with SAGE Publishing, as required

The ideal candidate will: 

  • be a recognised expert in biomedical research, toxicology, regulatory affairs, alternative method development and/or validation, or in any discipline within the scope of the journal
  • have strong leadership and organisational qualities and experience of chairing meetings
  • have a strong academic research or teaching background in a recognised university or equivalent institution
  • have strong experience of writing for, reviewing for and/or working on a journal, in the capacity of Editor or as an Editorial Board member
  • have a passion for the ongoing need to promote non-animal alternatives and the Three Rs; this should include strong links with associations and institutions relevant to this area
  • have a good understanding of the peer review process, as well as a knowledge of peer review and publication ethics
  • be organised, responsive, proactive and driven
  • be expected to dedicate around four hours per week to journal responsibilities

A modest editorial remuneration of £8500 p.a, as well as reasonable travel expenses is offered. The role would be for a period of 3 years initially.

SAGE and FRAME invite experessions of interest by 31st January 2020. Those interested in making an application should send a brief CV (no more than three pages) and a covering letter, which includes suggestions for journal development strategies such as a series of special issues.

All enquiries and expressions of interest should be directed via email in the first instance to:

Jennie Atkinson, Senior Publishing Editor, Medicine and Life Sciences at 

Related Posts
The FRAME Alternatives Laboratory (FAL) has developed an in vitro model to study fatty liver
The global study commissioned by FRAME has revealed that 93.4% of people think more needs
Dr Carol Treasure, the Founder and CEO of specialist animal-free contract testing laboratory XCellR8, has